Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription Articles published in Am J Pathol Retrieve available abstracts of 8 articles: HTML format

Single Articles

December 2023
1. CULIG Z, Puhr M
   Androgen receptor interacting proteins in prostate cancer development and therapy resistance.
   Am J Pathol. 2023 Dec 15:S0002-9440(23)00461.
   PubMed     Abstract available
   
   
   June 2023
2. ZHANG Y, Li W, Guo S, Wu Z, et al
   FBXO22 mediates the NGF/TRKA signaling pathway in bone metastases in prostate cancer.
   Am J Pathol. 2023 Jun 8:S0002-9440(23)00204-3. doi: 10.1016/j.ajpath.2023.
   PubMed     Abstract available
   
   
   
3. HANDLE F, Puhr M, Gruber M, Andolfi C, et al
   The oncogenic protein kinase/ATPase RIOK1 is up-regulated via the MYC/E2F transcription factor axis in prostate cancer.
   Am J Pathol. 2023 Jun 8:S0002-9440(23)00205-5. doi: 10.1016/j.ajpath.2023.
   PubMed     Abstract available
   
   
   February 2023
4. ROY A, Prasad S, Chen Y, Chao Y, et al
   Protein kinase D2 and 3 promote prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner.
   Am J Pathol. 2023 Feb 3:S0002-9440(23)00036-6. doi: 10.1016/j.ajpath.2023.
   PubMed     Abstract available
   
   
   January 2023
5. YU YP, Liu S, Ren BG, Nelson J, et al
   Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-institutional Analysis.
   Am J Pathol. 2023 Jan 18:S0002-9440(23)00029.
   PubMed     Abstract available
   
   
   October 2022
6. LOW JY, Ko M, Hanratty B, Patel RA, et al
   Genomic Characterization of Prostatic Basal Cell Carcinoma.
   Am J Pathol. 2022 Oct 26. pii: S0002-9440(22)00320.
   PubMed     Abstract available
   
   
   June 2022
7. MURESAN XM, Slabakova E, Prochazkova J, Drapela S, et al
   Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis.
   Am J Pathol. 2022 Jun 21. pii: S0002-9440(22)00174.
   PubMed     Abstract available
   
   
   February 2022
8. OFFERMANN A, Joerg V, Becker F, Roesch MC, et al
   Inhibition of CDK8/CDK19 suppresses its pro-oncogenic effects in prostate cancer.
   Am J Pathol. 2022 Feb 15. pii: S0002-9440(22)00047.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.